大行評級丨大摩:相信美的A股股價45天內有約逾八成機會跑贏大市 目標價94元
摩根士丹利發表研報指,國家發改委公佈2025年消費品以舊換新計劃細節,該計劃的覆蓋範圍更為廣泛,補貼空調數量亦有所增加。當中,政策細節略優於預期,尤其是空調方面。大摩預計,美的等領先家電企業應會受益更多,並在短期內看到正面的股價反應。美的A及H股的2025年市盈率預測均約為13倍,略低於美的A股自2017年以來的平均水平,但略高於美的H股自去年9月上市以來的平均水平。大摩亦預期,美的2024至2026財年每股盈利預測複合年均增長率處於低雙位數水平,認為該股具吸引力,同時相信其A股股價於45天內有約逾80%機會跑贏大市。該行將美的A股目標價定於94元,給予“增持”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.